Baricitinib as potential treatment for 2019-nCoV acute respiratory disease (vol 395, pg e30, 2020)

被引:1
|
作者
Richardson, Peter
Griffin, Ivan
Tucker, Catherine
Smith, Dan
Oechsle, Olly
Phelan, Anne
Rawling, Michael [1 ]
Savory, Edward [1 ]
Stebbing, Justin
机构
[1] BenevolentAI, London, England
来源
LANCET | 2020年 / 395卷 / 10241期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1906 / 1906
页数:1
相关论文
共 43 条
  • [41] Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (vol 32, pg 345, 2019)
    Pfeifer, H.
    Cazzaniga, G.
    van der Velden, V. H. J.
    Cayuela, J. M.
    Schafer, B.
    Spinelli, O.
    Akiki, S.
    Avigad, S.
    Bendit, I.
    Borg, K.
    Cave, H.
    Elia, L.
    Reshmi, S. C.
    Gerrard, G.
    Hayette, S.
    Hermanson, M.
    Juh, A.
    Jurcek, T.
    Chillon, M. C.
    Homburg, C.
    Martinelli, G.
    Kairisto, V.
    Lange, T.
    Lion, T.
    Mueller, M. C.
    Pane, F.
    Rai, L.
    Damm-Welk, C.
    Sacha, T.
    Schnittger, S.
    Touloumenidou, T.
    Valerhaugen, H.
    Vandenberghe, P.
    Zuna, J.
    Serve, H.
    Herrmann, E.
    Markovic, S.
    van Dongen, J. J. M.
    Ottmann, O. G.
    LEUKEMIA, 2020, 34 (07) : 1970 - 1970
  • [42] Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial (vol 7, pg e100, 2020)
    Walker, I
    Panzarella, T.
    Couban, S.
    LANCET HAEMATOLOGY, 2020, 7 (03): : E191 - E191